DRIO vs. LAKE, RCEL, LNSR, SPAI, LUCD, INO, HYPR, PDEX, OBIO, and NSPR
Should you be buying DarioHealth stock or one of its competitors? The main competitors of DarioHealth include Lakeland Industries (LAKE), Avita Medical (RCEL), LENSAR (LNSR), Safe Pro Group (SPAI), Lucid Diagnostics (LUCD), Inovio Pharmaceuticals (INO), Hyperfine (HYPR), Pro-Dex (PDEX), Orchestra BioMed (OBIO), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry.
DarioHealth vs. Its Competitors
DarioHealth (NASDAQ:DRIO) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.
Lakeland Industries has a net margin of -11.22% compared to DarioHealth's net margin of -162.73%. Lakeland Industries' return on equity of -3.07% beat DarioHealth's return on equity.
In the previous week, DarioHealth and DarioHealth both had 3 articles in the media. Lakeland Industries' average media sentiment score of 0.77 beat DarioHealth's score of 0.48 indicating that Lakeland Industries is being referred to more favorably in the news media.
DarioHealth has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500.
Lakeland Industries has higher revenue and earnings than DarioHealth. Lakeland Industries is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.
DarioHealth currently has a consensus price target of $40.00, suggesting a potential upside of 206.75%. Lakeland Industries has a consensus price target of $25.00, suggesting a potential upside of 55.86%. Given DarioHealth's higher probable upside, equities research analysts plainly believe DarioHealth is more favorable than Lakeland Industries.
33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are owned by institutional investors. 11.2% of DarioHealth shares are owned by company insiders. Comparatively, 1.9% of Lakeland Industries shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Lakeland Industries beats DarioHealth on 11 of the 16 factors compared between the two stocks.
Get DarioHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
DarioHealth Competitors List
Related Companies and Tools
This page (NASDAQ:DRIO) was last updated on 10/16/2025 by MarketBeat.com Staff
